Introduction
============

Infertility is defined as a couple's failure to achieve clinical pregnancy after 1 year of regular unprotected sexual intercourse \[[@b1-cerm-2018-00423]\]. Infertility is a global problem with a major impact on quality of life. The rate of infertility varies across different areas \[[@b2-cerm-2018-00423]\], and it affects about 8%--15% of couples all over the world. Approximately 40% of all infertility cases are related to male factors \[[@b3-cerm-2018-00423]\], of which 37%--58% are classified as idiopathic male infertility. Idiopathic male infertility may be caused by various factors, including chronic stress and endocrine disorders that result from environmental pollution, reactive oxygen species, and genetic abnormalities \[[@b4-cerm-2018-00423]\]. Spermatogenesis is a complex process that is regulated by multiple genes \[[@b5-cerm-2018-00423]\], some of which are involved in the folate-dependent 1-carbon metabolism pathway. This pathway includes the metabolism of homocysteine and folate \[[@b6-cerm-2018-00423]\]. Folate is necessary for thymidylate and purine biosynthesis and acts as a substrate for many biological reactions, such as 1-carbon-unit transfer, DNA synthesis, cell division and proliferation, the metabolism of several amino acids, transmethylation, and transsulfuration \[[@b7-cerm-2018-00423]\]. As such, this pathway plays a key role in DNA synthesis during the process of spermatogenesis. It has been shown that folate, homocysteine, and their derivatives are important factors in spermatogenesis \[[@b8-cerm-2018-00423]\]. Disorders of folate metabolism may lead to sperm DNA damage, which affects sperm quality, count, motility, and morphology \[[@b9-cerm-2018-00423]\]. The main enzymes of this pathway include 5,10-methylenetetrahydrofolate dehydrogenase (MTHFD), 5,10-methenyltetrahydrofolate cyclohydrolase, 10-formyltetrahydrofolate synthetase, serine hydroxymethyltransferase, and methionine synthase (MS; encoded by *MTR*) \[[@b10-cerm-2018-00423]\]. MS is a key enzyme participating in folate-dependent 1-carbon metabolism and DNA synthesis, methylation, and repair \[[@b1-cerm-2018-00423]\]. MS has four binding sites for cobalamin (vitamin B~12~), homocysteine, 5-methyltetrahydrofolate, and S-adenosyl methionine \[[@b2-cerm-2018-00423],[@b3-cerm-2018-00423]\]. The gene that codes MS, *MTR*, is located at 1q43. MS is a vitamin B~12~-dependent enzyme that catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine in order to produce methionine and tetrahydrofolate. Tetrahydrofolate is necessary for nucleotide synthesis, and methionine is required for the synthesis of S-adenosyl methionine and the transfer of a methyl group from S-adenosyl methionine to DNA \[[@b4-cerm-2018-00423]\]. In this pathway, 5- and 10-methyltetrahydrofolate participate in DNA synthesis through the replacement of dUTP with dTTP \[[@b5-cerm-2018-00423],[@b11-cerm-2018-00423]\]. Mutations in the *MTR* gene result in a reduction of methylcobalamin levels, leading to homocystinuria, a condition characterized by increased homocysteine and decreased methionine levels in blood \[[@b6-cerm-2018-00423]\]. Various studies have shown a relationship between the 2756A\>G polymorphism in the coding region of *MTR* and some disorders. It has been reported that the *MTR* 2756A\>G polymorphism leads to the replacement of aspartic acid with glycerol \[[@b7-cerm-2018-00423],[@b8-cerm-2018-00423]\]. Other studies have found a negative relationship between the GG genotype and homocysteine, suggesting increased enzyme activity at the time of the occurrence of the polymorphism in the *MTR* gene in sperm DNA \[[@b9-cerm-2018-00423]\]. Several studies have revealed a relationship between the *MTR* 2756A\>G polymorphism and the pathogenesis of Alzheimer disease, and associations with other disorders such as cancer, chromosomal disorders, Parkinson disease, and loss of pregnancy have also been investigated \[[@b12-cerm-2018-00423],[@b13-cerm-2018-00423]\]. Very few studies have explored the possible association of the 2756A\>G polymorphisms in the coding region of *MTR* with male infertility, and the existing studies on this topic have reported inconsistent results. Some studies have reported no relationship between the 2756A\>G polymorphism in the *MTR* coding region and infertility caused by nonobstructive azoospermia \[[@b10-cerm-2018-00423],[@b14-cerm-2018-00423]\], while in another study, a statistically significant relationship was found between the 2756A\>G polymorphism in the *MTR* coding region and idiopathic infertility \[[@b15-cerm-2018-00423]\]. Since no study has yet been conducted of the *MTR* 2756A\>G polymorphism in the coding region of the *MTR* gene and its relationship with idiopathic male infertility in the Iranian population, this study aimed to determine the prevalence of the *MTR* 2756A\>G polymorphism and to investigate its relationship with idiopathic male fertility in this population.

Methods
=======

1. Study population
-------------------

The participants of this study included 200 men from the west and northwest of Iran, of whom 100 had idiopathic infertility and 100 were healthy men included as the control group. The men in the control group had previously fathered at least one healthy child. Informed written consent was obtained from all participants prior to enrollment in the study. The subjects' mean age was 35±5 years (range, 20--48 years). The inclusion criteria for this study were idiopathic male infertility after at least 1 year of regular unprotected sexual intercourse (2--3 times a week), normal findings on a transvaginal ultrasound examination of their female partner, and no history of pelvic inflammatory disease or abdominal surgery. The exclusion criteria consisted of disorders such as prostatitis, urethritis, varicocele, diabetes, and parotiditis; chromosomal disorders; genital or urethral obstructive lesions; a history of cryptorchidism in childhood; and occupational risks.

2. Sampling and data collection
-------------------------------

This case-control study was performed after receiving permission from the ethics committee of AJA University of Medical Sciences (IR,AJAUMS.REC. 1396.113). All participants underwent clinical and laboratory examinations, a physical examination, and a sperm analysis, which assessed number, motility, viability, and morphology in accordance with the World Health Organization guidelines \[[@b16-cerm-2018-00423]\]. From every individual in both groups, 2 mL of blood was collected in sterile tubes containing EDTA (EDTA K3E 15%, 0.12 mL; BD Vacutainer, BD Vacutainer Systems, Plymouth, UK), and the blood samples were stored at −20℃ before DNA extraction.

3. Primers
----------

Genotyping of the *MTR* polymorphism was performed using the polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique. The sequences of the primer set used to identify different point mutations in the 2756 region of the *MTR* gene in each allele were as follows: 5′-CCA GGG TGC CAG GTA TAC AG-3′ and 5′-CC-3GCC TTT TTA CAC TCC TCA AAA-3′. These primers were used to amplify a target sequence of 498 base pairs.

4. Genotyping and PCR-RFLP
--------------------------

PCR was performed in a 25-μL reaction mixture containing 250 μM of dNTP solution, 2.5 units of DNA Taq polymerase enzyme (Fermentas, Glen Burnie, MD, USA), 10× buffer, 1.5 mM MgCl~2~, 10 mM Tris-HCl, 50 mM KCl, 10 pmol of each primer (CinnaGen Inc., Tehran, Iran), and 4 μL of the extracted DNA. The thermal cycling conditions for replication of *MTR* were as follows: initial denaturation at 90℃ for 4 minutes, 34 cycles at 94℃ for 1 minute, annealing for 1 minute at 56℃, and extension for 1 minute at 73℃, followed by a final extension at 72℃ for 10 minutes. The PCR products were analyzed by electrophoresis in 1.2% (w/v) agarose gel after DNA staining and visualized under ultraviolet transillumination. Then, the PCR product was digested for 16 hours at 37℃ by the HaeIII enzyme. Finally, electrophoresis on 1.5% agarose gel was used to evaluate the enzyme efficiency. The results of the PCR products were statistically analyzed to assess the relationship between the point mutation in the 2756 region of the *MTR* gene with the occurrence of infertility in the study population.

5. Data analysis
----------------

The chi-square and Fisher tests were used to evaluate the association between polymorphisms in the 2756 region of the *MTR* gene and infertility in both groups (control and idiopathic male infertility groups). The statistical analysis was done separately and in combination. The results were reported as frequency and percentage, and *p-*values \<0.05 were considered to indicate statistical significance. The obtained data were analyzed using IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, USA).

Results
=======

The mean age of the participants was 35±5 years. In our study, the *MTR* 2756A\>G polymorphism was analyzed using a RFLP-PCR system in 100 infertile and 100 fertile men. The results of genotyping of the *MTR* 2756A\>G polymorphism by PCR-RFLP are presented in [Figure 1](#f1-cerm-2018-00423){ref-type="fig"}. The allele and genotype distributions of the A2756G polymorphism were 4%, 31.5%, 64.5%, 19.5%, and 80.5% for GG, GA, AA, G, and A, respectively. The frequencies of the A and G alleles were 77% and 23% in the infertile patients, and 84% and 16% in the control group. The frequency of the GG, GA, and AA genotypes was 5%, 36%, and 59%, respectively, in the infertile group and 3%, 27%, and 70% in the control group ([Table 1](#t1-cerm-2018-00423){ref-type="table"}). The *MTR* 2756A\>G polymorphism was present in both groups.

[Table 2](#t2-cerm-2018-00423){ref-type="table"} presents the distribution of the *MTR* 2756A\>G polymorphism in the infertile and control groups. There was no significant difference in the ratios of the AA/GG, AA/GA, and GA/GG genotypes of the *MTR* 2756A\>G polymorphism in either group (*p*\>0.05). No significant difference was found between the infertile and control groups in the frequency of the GG genotype compared with that of the GA and AA genotypes for the *MTR* 2756A\>G polymorphism (*p*=0.453). Furthermore, no significant difference was detected between the two groups in terms of the ratio of GA and GG genotypes versus AA genotypes (*p*=0.113). In general, no significant difference was found between the two groups in the frequency of the *MTR* 2756A\>G polymorphism in any genetic model.

Discussion
==========

This study investigated the relationship between a single-nucleotide polymorphism in the *MTR* gene (*MTR* 2756A\>G) and the risk for idiopathic male infertility in men from the west and northwest of Iran. To the best of our knowledge, no study has been conducted of the *MTR* 2756A\>G polymorphism and its association with idiopathic male infertility in this.

MS is an enzyme that catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine and methionine, resulting in tetrahydrofolate production. Furthermore, 5- and 10-methyltetrahydrofolate participate in DNA synthesis through the replacement of dUTP with dTTP \[[@b4-cerm-2018-00423]\].

In this study, the frequencies of A and G alleles were 77% and 23%, respectively, in the infertile patients versus 84% and 16%, respectively, in the control group. The frequency of the AA, GG, and GA genotypes was 59%, 5%, and 36%, respectively, in infertile subjects compared to 70%, 3%, and 27%, respectively, in the control group of healthy men.

The results obtained from our study indicate that the ratio of the AA and GG genotypes for the *MTR* 2756A\>G polymorphism in patients with idiopathic infertility was not significantly different from that of the control group. The same result was obtained for the GG and GA genotypes. Furthermore, there was no statistically significant difference in the frequency of the A allele between the infertile and control groups. The results of this study also showed no significant association between the GG genotype and idiopathic male infertility. Overall, the findings of this study indicate that there is no relationship between the *MTR* 2756A\>G polymorphism and male infertility.

In a study conducted by Kim et al. \[[@b17-cerm-2018-00423]\] on polymorphisms of *MTR*, a significant association was found between mutations of the *MTR* gene in the 2756 region and loss of pregnancy in women. In another study by Lee et al. \[[@b4-cerm-2018-00423]\] in South Korea on three common enzymes (MTHFR, MS, and MS reductase) involved in folate metabolism that play a key role in DNA synthesis and methylation reactions, a significant association was found between mutations of the *MTR* gene in the 2756 region and azoospermia in nonobstructive infertile men with no further chromosomal disorders.

Consistent with our findings, Weiner et al. \[[@b10-cerm-2018-00423]\], in a study conducted in Russia, stated that *MTR* gene mutations in the 2756 region did not have any significant relationship with azoospermia, although they found that an *MTR* gene mutation in the 2756 region was significantly associated with decreased serum level of progesterone. In a study by Kurzawski et al. \[[@b18-cerm-2018-00423]\] in Poland that investigated the relationship between genetic variations in folate-dependent enzymes and nonobstructive male infertility, no significant difference was found in genotype or allele frequency between infertile and healthy fertile men, and no relationship was found between *MTR* gene mutations and nonobstructive male infertility in the Polish population.

Conversely, in the study conducted by Gava et al. \[[@b19-cerm-2018-00423]\] in Brazil, idiopathic male infertility with nonobstructive azoospermia or severe oligozoospermia was significantly associated with the *MTR* 2756A\>G polymorphism (*p*=0.017), although no statistically significant difference was found for the MTHFR 677C\>T polymorphism. Nevertheless, the statistical analysis did not suggest any relationship between the severe oligozoospermia group and the control group. Their findings suggested that the *MTR* 2756A\>G polymorphism could be an important genetic predisposing factor for idiopathic infertility in Brazilian men.

Various studies in different populations have reported inconsistent results regarding this relationship. This inconsistency has also been seen for the other genes involved in the folate pathway. MTHFR and MTHFD play critical roles in DNA synthesis and remethylation \[[@b4-cerm-2018-00423],[@b10-cerm-2018-00423],[@b14-cerm-2018-00423],[@b20-cerm-2018-00423]\]. Associations of polymorphisms of the genes encoding these enzymes with male infertility have also been investigated in several studies, with divergent results. Some studies reported that common polymorphisms in critical genes of the folate pathway were major risk factors for idiopathic male infertility \[[@b4-cerm-2018-00423],[@b10-cerm-2018-00423],[@b21-cerm-2018-00423]-[@b24-cerm-2018-00423]\], but other studies yielded the opposite results \[[@b10-cerm-2018-00423],[@b18-cerm-2018-00423],[@b25-cerm-2018-00423]\].

In conclusion, the findings of the current study suggest that the *MTR* 2756A\>G polymorphism is not a predisposing factor for idiopathic infertility in Iranian men. However, more research on different populations is required to address the role of polymorphisms in different genes in idiopathic male infertility.
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###### 

Allele and genotype frequencies for *MTR* 2756A\>G in infertile men and controls

  Variable           Infertility (n = 100)   Control (n = 100)   Total (n = 200)
  ------------------ ----------------------- ------------------- -----------------
  Allele frequency                                               
   A allele          154 (77)                168 (84)            322 (80.5)
   G allele          46 (23)                 32 (16)             78 (19.5)
  Genotype                                                       
   AA                59 (59)                 70 (70)             129 (64.5)
   GA                36 (36)                 27 (27)             63 (31.5)
   GG                5 (5)                   3 (3)               8 (4)

Values are presented as number (%).

###### 

Genotype distribution analysis as a risk factor for male infertility compared to controls

  *MTR* 2756A \> G (infertility case--control)   Odds ratio (95% CI)    *p*-value
  ---------------------------------------------- ---------------------- -----------
  A vs. G                                        1.568 (0.772--3.187)   0.212
  AA vs. GG                                      2.004 (0.460--8.744)   0.346
  AA vs. GA                                      1.560 (0.848--2.869)   0.151
  GA vs. GG                                      1.286 (0.282--5.860)   0.745
  GA/AA vs. GG                                   1.738 (0.404--7.475)   0.453
  AA vs. GG/GA                                   0.623 (0.347--1.120)   0.113

CI, confidence interval.
